Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF).

Authors :: Sherwood, Matthew W
Douketis, James D
Patel, Manesh R
Piccini, Jonathan P
Hellkamp, Anne S
Lokhnygina, Yuliya
Spyropoulos, Alex C
Hankey, Graeme J
Singer, Daniel E
Nessel, Christopher C
Mahaffey, Kenneth W
Fox, Keith A A
Califf, Robert M
Becker, Richard C
ROCKET AF Investigators
Source :: Circulation; 5/6/2014, Vol. 129 Issue 18, p1850-1859, 10p
Publication Year :: 2014

Full Text Access

Tools